Lifting the California mask mandate basically says chronically ill and disabled lives don’t matter
By Dipti S. Barot,
San Francisco Chronicle
| 02. 16. 2022
Photo by Kai Pilger on Unsplash
As the omicron surge wanes, and the experts read the sewage like tea leaves, states from New York to California and everywhere in between have rushed to remove mask mandates, declaring that we have reached the magic inflection point between pandemic and endemic. And, once again, it will be the medically vulnerable who will suffer the casualties in this premature push for normalcy while COVID deaths in the U.S. still average near 2,500 per day.
One can’t help but recall the disastrous Centers for Disease Control and Prevention decision to recommend removing mask mandates in May 2021 and the subsequent walk back a mere two months later due to the delta variant. Even as we learn about long COVID and its disastrous effects, why do these policies reflect a greater concern for the robustness of the economy than the robustness of its citizens?
For me, an immunocompromised physician, the true kickoff to the pandemic was two Februaries ago when a colleague persisted in flouting our clinic’s coronavirus distancing guidelines by approaching too close and...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...